Oral bacteriotherapy for viral gastroenteritis

• Published in: Digestive diseases and sciences Vol. 39; no. 12; p. 2595
• Main Authors: Isolauri, E, Kaila, M, Mykkänen, H, Ling, W H, Salminen, S
• Format: Journal Article
• Language: English
• Published: United States 01.12.1994
• Subjects: Administration, Oral; beta-Glucosidase - analysis; Diarrhea, Infantile - therapy; Diarrhea, Infantile - virology; Feces - chemistry; Feces - microbiology; Fluid Therapy; Gastroenteritis - therapy; Gastroenteritis - virology; Glucuronidase - analysis; Humans; Infant; Intestines - microbiology; Lactobacillus casei; Rotavirus Infections - therapy; Urease - analysis
• ISSN: 0163-2116
• DOI: 10.1007/bf02087695

The effect of orally administered lactobacilli on acute rotavirus diarrhea was tested in 42 well-nourished children ages 5-28 months. After oral rehydration, the patients were randomized to a study group, receiving human Lactobacillus casei strain GG 10(10) colony-forming units twice daily for five days, or a control group not given lactobacilli. Lactobacillus GG was found in the feces in 83% of the study group. The diarrheal phase was shortened in that group. Dietary supplementation with lactobacilli significantly influenced the bacterial enzyme profile: urease activity during diarrhea transiently increased in the control group but not in the study group; F = 8.6, P = 0.01. No intergroup differences were found in beta-glucuronidase, beta-glucosidase, and glycocholic acid hydrolase levels. We suggest that rotavirus infection gives rise to biphasic diarrhea, the first phase being an osmotic diarrhea and the second associated with overgrowth of specifically urease-producing bacteria. Oral bacteriotherapy appears a promising means to counteract the disturbed microbial balance.